纳米泡超声造影剂的时间-强度曲线分析与肿瘤外渗研究
本研究在小鼠乳腺癌和卵巢癌模型中比较了Pluronic稳定脂质纳米泡与微泡的体内分布和外渗,结果显示两组在肿瘤、肝、肾的峰值增强无显著差异,但纳米泡在肿瘤和肾的衰减速率显著慢于微泡,且3小时时纳米泡在肿瘤组织中的滞留程度更高,提示纳米泡在超声分子成像和药物递送方面有应用前景。
要点
- 纳米泡与微泡在肿瘤、肝、肾的峰值增强无显著差异。
- 纳米泡在肿瘤和肾的衰减速率显著慢于微泡。
- 3小时时纳米泡在肿瘤组织中滞留程度高于微泡。
核心结论
- 纳米泡与微泡相比具有独特的行为特征,支持其在超声分子成像和药物递送中超越肿瘤血管的应用。
研究设计与样本
- 研究使用Pluronic稳定脂质全氟丙烷纳米泡和标准脂质稳定全氟丙烷微泡,经尾静脉注射入荷BC4 T1原位乳腺癌或OVCAR-3皮下卵巢癌的小鼠,进行灌注动态研究。
关键影像表现/征象
- 纳米泡与微泡在肿瘤、肝、肾三个区域的峰值增强无显著差异。
- 在BC4 T1荷瘤小鼠的肿瘤和肾中,以及OVCAR-3荷瘤小鼠中,纳米泡的衰减速率显著慢于微泡。
- 组织学分析显示,在两种肿瘤模型中,3小时时间点纳米泡在肿瘤组织中的滞留程度高于微泡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Our group recently presented a simple strategy using the non-ionic surfactant, Pluronic, as a size control excipient to produce nanobubbles in the 100-nm range, which exhibited stability and echogenicity on par with clinically available microbubbles. The objective of the present study was to evaluate biodistribution and extravasation of the Pluronic-stabilized lipid nanobubbles compared with microbubbles in 2 experimental tumor models in mice. Standard lipid-stabilized perfluoropropane bubbles (Pluronic L10) and lipid-stabilized perfluoropropane nanobubbles were intravenously injected into mice bearing either an orthotopic mouse breast cancer (BC4 T1) or subcutaneous mouse ovarian cancer (OVCAR-3) through the tail vein to perform perfusion dynamic studies. No significant differences between the nanobubble and microbubble groups were observed in the peak enhancement of the 3 tested regions (tumor, liver and kidney). However, the decay rates of nanobubble in the tumor and kidney of BC4 T1-bearing mice, as well as in mice with OVRCAR-3 tumors were significantly slower than those of the microbubble. To quantify extravasation, fluorescently labeled bubbles were intravenously injected into mice bearing the same tumors. Histologic analysis showed that nanobubbles were retained in tumor tissue to a greater extent compared with microbubbles in both tumor models at the 3-h time point. Our results demonstrate unique nanobubble behavior compared with microbubbles and support augmented application of these agents in ultrasound molecular imaging and drug delivery beyond the tumor vasculature.
引用
- Wu H, Abenojar EC, Perera R, et al. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents. Ultrasound Med Biol. 2019. PMID: 31248638. doi:10.1016/j.ultrasmedbio.2019.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。